Christopher Darr
About
Christopher Darr is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology.
According to data from OpenAlex, Christopher Darr has authored 58 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 21 papers in Surgery and 20 papers in Oncology. Recurrent topics in Christopher Darr's work include Bladder and Urothelial Cancer Treatments (15 papers), Prostate Cancer Treatment and Research (14 papers) and Renal cell carcinoma treatment (11 papers). Christopher Darr is often cited by papers focused on Bladder and Urothelial Cancer Treatments (15 papers), Prostate Cancer Treatment and Research (14 papers) and Renal cell carcinoma treatment (11 papers). Christopher Darr collaborates with scholars based in Germany, Hungary and Switzerland. Christopher Darr's co-authors include Boris Hadaschik, Ken Herrmann, Stephan Tschirdewahn, Claudia Kesch, Jan Philipp Radtke, Ulrich Krafft, Viktor Grünwald, Henning Reis, Tibor Szarvas and Gerhard Weinreich and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Theranostics.
In The Last Decade
Christopher Darr
49 papers receiving 497 citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Christopher Darr Germany | 11 | 272 | 135 | 131 | 110 | 76 | 58 | 501 | ||
| Michael Autenrieth Germany | 14 | 259 1.0× | 193 1.4× | 115 0.9× | 157 1.4× | 68 0.9× | 45 | 557 | ||
| Mohamed Ismail United Kingdom | 12 | 339 1.2× | 111 0.8× | 86 0.7× | 57 0.5× | 161 2.1× | 50 | 591 | ||
| Christopher Pieczonka United States | 12 | 433 1.6× | 142 1.1× | 136 1.0× | 111 1.0× | 56 0.7× | 69 | 679 | ||
| Susanna Cattarino Italy | 16 | 484 1.8× | 66 0.5× | 114 0.9× | 157 1.4× | 113 1.5× | 48 | 671 | ||
| Henriette Lindberg Denmark | 14 | 268 1.0× | 145 1.1× | 167 1.3× | 122 1.1× | 76 1.0× | 40 | 599 | ||
| Marina Orevi Israel | 14 | 216 0.8× | 151 1.1× | 225 1.7× | 152 1.4× | 51 0.7× | 23 | 577 | ||
| Sabina Sevcenco Austria | 13 | 297 1.1× | 126 0.9× | 63 0.5× | 187 1.7× | 147 1.9× | 39 | 512 | ||
| Tomohiro Taki Japan | 11 | 171 0.6× | 114 0.8× | 143 1.1× | 41 0.4× | 89 1.2× | 48 | 438 | ||
| Martijn B. Busstra Netherlands | 13 | 316 1.2× | 103 0.8× | 124 0.9× | 126 1.1× | 78 1.0× | 32 | 493 | ||
| Jessica A. Smith United States | 9 | 140 0.5× | 74 0.5× | 159 1.2× | 39 0.4× | 42 0.6× | 23 | 464 |
Countries citing papers authored by Christopher Darr
Since
Specialization
Citations
This map shows the geographic impact of Christopher Darr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Darr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Darr more than expected).
Fields of papers citing papers by Christopher Darr
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Christopher Darr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Darr. The network helps show where Christopher Darr may publish in the future.
Co-authorship network of co-authors of Christopher Darr
This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Darr. A scholar is included among the top collaborators of Christopher Darr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Darr. Christopher Darr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Darr, Christopher, Elai Davicioni, Kuangyu Shi, et al.. (2025). Transcriptomic Profiling of the Tumor Immune Microenvironment Reveals Prognostic Markers in mCRPC Patients Treated with LuPSMA Therapy. Theranostics. 15(18). 9447–9458.
2.
Oláh, Csilla, Boris Hadaschik, Christopher Darr, et al.. (2025). Spatial distribution and subtype‐specific expression patterns of Nectin‐4 in muscle‐invasive bladder cancer. British Journal of Urology. 136(2). 297–305.
3.
Kesch, Claudia, Volker Meyer, C. Praus, et al.. (2025). A phase I/II study of neoadjuvant, intra-arterial administration of (177Lu)lutetium vipivotide tetraxetan in subjects with high-risk, localised or locally advanced prostate cancer (LUPUS).. Journal of Clinical Oncology. 43(5_suppl).
4.
Paffenholz, Pia, Jozefina Casuscelli, Emily Rinderknecht, et al.. (2025). Real world evidence from a retrospective multi-center analysis on first-line therapy for metastatic renal cell carcinoma with chromophobe histology.. Journal of Clinical Oncology. 43(5_suppl). 488–488.
5.
Darr, Christopher, Jens Bedke, Philipp Ivanyi, et al.. (2025). Treatment of Advanced or Metastatic Urothelial Cancer. Oncology Research and Treatment. 49(1-2). 4–12.
6.
Casuscelli, Jozefina, Thomas Büttner, Christopher Darr, et al.. (2025). Enfortumab vedotin plus pembrolizumab in metastatic urothelial carcinoma: First results on outcomes and safety in a German multicenter real-world patient cohort (GUARDIANS).. Journal of Clinical Oncology. 43(5_suppl). 715–715.
7.
Paffenholz, Pia, Katrin Schlack, Marco J. Schnabel, et al.. (2024). Breaking boundaries: Exploring extended pembrolizumab in first-line treatment of renal cell carcinoma with axitinib-pembrolizumab combination.. Journal of Clinical Oncology. 42(4_suppl). 436–436.
8.
Klümper, Niklas, Thomas Büttner, Alexander Höllein, et al.. (2024). Safety and efficacy of enfortumab vedotin in patients with metastatic/locally advanced urothelial cancer: Real-world evidence from a European database.. Journal of Clinical Oncology. 42(4_suppl). 553–553.
9.
Grünwald, Viktor, Benjamin Martin, Günter Niegisch, et al.. (2024). Final Analysis of a Noninterventional Study on Cabozantinib in Patients With Advanced Renal Cell Carcinoma After Prior Checkpoint Inhibitor Therapy of the German Interdisciplinary Working Group on Renal Tumors (IAG-N). Clinical Genitourinary Cancer. 22(5). 102159–102159.
10.
Heitmann, Jonas S., Juliane S. Walz, Birgit Federmann, et al.. (2023). Clinical development of the bispecific PSMAxCD3 antibody CC-1.. Journal of Clinical Oncology. 41(16_suppl). 2534–2534.
11.
Darr, Christopher, et al.. (2023). Metastatic Prostate Cancer—A Review of Current Treatment Options and Promising New Approaches. Cancers. 15(2). 461–461.
12.
Darr, Christopher, et al.. (2023). Neue Therapieansätze und Studienübersicht beim metastasierten hormonsensitiven Prostatakarzinom. PubMed. 62(4). 369–375.
13.
Wiesenfarth, Manuel, Vivienn Weru, Stephan Tschirdewahn, et al.. (2022). Detection of Clinically Significant Prostate Cancer Using Targeted Biopsy with Four Cores Versus Target Saturation Biopsy with Nine Cores in Transperineal Prostate Fusion Biopsy: A Prospective Randomized Trial. European Urology Oncology. 6(1). 49–55.
14.
Darr, Christopher, Stefanie Zschäbitz, Günter Niegisch, et al.. (2022). 1759P Enfortumab vedotin in metastatic urothelial carcinoma: Retrospective multicentre patient cohort. Annals of Oncology. 33. S1342–S1342.
15.
Costa, Pedro Fragoso, Wolfgang P. Fendler, Ken Herrmann, et al.. (2021). Radiation Protection and Occupational Exposure on 68Ga-PSMA-11–Based Cerenkov Luminescence Imaging Procedures in Robot-Assisted Prostatectomy. Journal of Nuclear Medicine. 63(9). 1349–1356.
16.
Collamati, F., Matthias N. van Oosterom, Boris Hadaschik, Pedro Fragoso Costa, & Christopher Darr. (2021). Beta radioguided surgery: towards routine implementation?. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 65(3). 229–243.
17.
Tschirdewahn, Stephan, Manuel Wiesenfarth, David Bonekamp, et al.. (2020). Detection of Significant Prostate Cancer Using Target Saturation in Transperineal Magnetic Resonance Imaging/Transrectal Ultrasonography–fusion Biopsy. European Urology Focus. 7(6). 1300–1307.
18.
Darr, Christopher, Manuel Wiesenfarth, Francesco Giganti, et al.. (2020). Three-dimensional Magnetic Resonance Imaging–based Printed Models of Prostate Anatomy and Targeted Biopsy-proven Index Tumor to Facilitate Patient-tailored Radical Prostatectomy—A Feasibility Study. European Urology Oncology. 5(3). 357–361.
19.
Weinreich, Gerhard, Christopher Darr, Georgios Stamatis, Thomas Hachenberg, & Sandra Kampe. (2015). Controlled-Release Oxycodone as “Gold Standard” for Postoperative Pain Therapy in Patients Undergoing Video-Assisted Thoracic Surgery or Thoracoscopy: A Retrospective Evaluation of 788 Cases. The Thoracic and Cardiovascular Surgeon. 63(6). 510–513.
20.
Kampe, Sandra, et al.. (2014). The impact of epidural analgesia compared to systemic opioid-based analgesia with regard to length of hospital stay and recovery of bowel function: retrospective evaluation of 1555 patients undergoing thoracotomy. Journal of Cardiothoracic Surgery. 9(1). 175–175.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Michael Autenrieth Breakdown of academic impact, for papers by Mohamed Ismail Breakdown of academic impact, for papers by Christopher Pieczonka Breakdown of academic impact, for papers by Susanna Cattarino Breakdown of academic impact, for papers by Henriette Lindberg Breakdown of academic impact, for papers by Marina Orevi Breakdown of academic impact, for papers by Sabina Sevcenco Breakdown of academic impact, for papers by Tomohiro Taki Breakdown of academic impact, for papers by Martijn B. Busstra Breakdown of academic impact, for papers by Jessica A. Smith